Pharma Externalization Strategies 2016


Externalization has become a key driver of pharma revenue, but to what extent are co-developed and acquired drugs driving growth, and is this trend here to stay?

Available for a limited time, our free 7-page sample report Externalization Strategies 2016 includes must-have analysis, a revenue forecast through 2024 and other essential data:

  • Deal activity between pharma and academic institutions and CROs— what you need to know
  • Actual case studies demonstrating open innovation in Big Pharma
  • Pipeline growth comparisons between Mid and Big Pharma
  • Growth drivers in Japan Pharma past, present and future

Stay informed on what you must know about the changing landscape of drug R&D. Download your copy of Pharma Externalization Strategies 2016 now.

Get a free sample report